COMPANY
ABOUT US
Bionutrion is developing a digital therapeutics to manage Metabolic dysfunction
Associated Steatotic Liver Disease (MASLD) using personalized nutrition
prescription and AI-based cognitive behavioral coaching programs.
The Dr.Coach app, which will be introduced for the first time
as a digital therapeutics for MASLD in Korea, can systematically perform
risk assessment, customized nutrition assessment,
and 1:1 cognitive behavioral coaching for fatty liver disease.
We also adopts food as a medicine,
using Green Protake as a medicine for a short time as a tool to make
you healthier supported by evidence based researches.
VISION / MISSION
VISION
Healthier You Through
Our Life Changing Metabolic Care
MISSION
OUR TECHNOLOGY
Study title | Effectiveness and safety of high protein meal replacements among people with obesity, a Randomized Controlled Trial |
---|---|
Study period | Total of 48 weeks |
CORE VALUE
Improving quality of life
through personalized, holistic care
Innovation through continuous research
and science based evidences
Connection to sustainable, healthy eating that benefits the Earth and You
The ability to believe in and bring out the best in people
Growth through inclusion of diverse people
Trust through transparent communication and high ethical standards
OUR HISTORY
Launched Slimlite as a diet meal replacement for weight control
Selected for NIPA digital healthcare demonstration project in cooperation with Bumin Hospital
Selected as a Data Voucher Project, selected as a Startup Voucher project, and won the Women's Business Startup Awards
Selected as an Agri-Food Venture Incubation Pproject
Invested USD 800,000 from Big Move Ventures
Planning to develop a check-up version of the Dr.Coach app
Completed a Phase 3 trial of a high protein meal replacements, hired a clinical dietitian, and made progress toward licensure of a digital therapeutics
Planning an update to the Dr.Coach app
Signed Memorandom Of Understanding with the EZCareTech, medical information company
Ulsan Angel Investment Matching Fund invested 500 million won, signed sales contract with LohasMedi Corp.
Signed Exclusive Right to implement patent with Seoul National University Bundang Hospital
Approval of corporate affiliated labs, venture company certification
First investment of USD 200,000 from Medytox Ventures, Started Dr. Coach app development
Signed Memorandom of Understanding between Waycen, AI based healthcare company and BTiwoom, IT company
PARTNERSHIP